- Illustration of a human corpus

Data driven clinical trials on virtual patients

Virtonomy is shortening time-to-market of medical products by conducting data driven studies on virtual patients. Our solution is based on an ever-expanding database to reflect anatomical variability, demographic diversity and pathological conditions.

The development costs of medical devices are rising along with time-to-market. Digital solutions are the only way to face these challenges.

Reduce risks, time and cost

by performing data-driven device development & virtual clinical trials using statistical analysis, simulations & optimization

Master new regulatory & ethical demands

by performing data-driven device development & virtual clinical trials using statistical analysis, simulations & optimization

Safe animal & clinical trials

by accessing Digital Twins based on clinical data of thousands of humans and animals

Use virtual patients as digital evidence

Regulatory viewpoint / FDA’s Perspective

FDA has identified an important role for modeling and simulation in its strategic priorities.

Useful links:

FDA’s view on virtual patients

“FDA’s Office of Science and Engineering Laboratories (OSEL) has committed significant resources for transforming computational modeling from a valuable scientific tool to a valuable regulatory tool because of its potential for significant cost-savings in evaluating medical devices, simulating performance under scenarios that may not be possible with human use or that could more effectively be evaluated with simulation.”

FDA prognosis für Virtual Patients data & Simulations


Our end-to-end digital twin solution

The virtual trial platform supports the full product life-cycle of medical device development.

Virtual Patients

Digital twins to better understand your target anatomy.

Statistical Analysis

Population based engineering to treat the maximum number of patients.


Simulate human and animal variability.

Regulatory Reporting

Three-dimensional visualization for marketing, education and training.

Understanding patient anatomies and optimizing anatomical fit directly impacts the fate of development projects. Virtonomy’s combined expertise in specific pathologies, device/patient interactions and state of the art therapy options is tremendously valuable for anyone looking to create or optimize cardiovascular technologies.

Dr. Maximilian Kütting, Director R&D

How can you shorten your time-to market?

Talk to our experts to find out how you can utilize digital twins for your specific medical device.

Supported by

Scroll to Top